STOCK TITAN

US$119 million Mobile-health (Nasdaq: MNDR) MOU targets BIMA and M&M Helix expansion

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Mobile-health Network Solutions reported a non-binding Strategic Cooperation Framework Memorandum of Understanding with Hector Capital Holdings. Under this framework, Hector Capital may invest up to US$119 million to help fund potential majority acquisitions of BIMA and M&M Helix, two digital health platforms operating across Asia and Africa.

The structure of the funding, which could include equity, convertible instruments or other securities, will be set in definitive agreements. Any transaction depends on full due diligence, independent valuation and required regulatory approvals, including under Nasdaq listing rules and Singapore law, so completion is not assured.

Positive

  • None.

Negative

  • None.

Insights

MNDR outlines a potentially large but fully non-binding US$119 million strategic deal.

Mobile-health Network Solutions and Hector Capital signed a non-binding framework where Hector Capital may invest up to US$119 million. The goal is to fund majority acquisitions of BIMA and M&M Helix, expanding MNDR’s AI-enabled health footprint in Asia and Africa.

The framework contemplates a mix of equity, convertible instruments or other financial structures, with proceeds directed to the acquisitions and broader corporate needs. However, the entire MOU is expressly non-binding and subject to full legal, financial and operational due diligence, independent valuation, and approvals under Nasdaq rules and Singapore law.

If definitive agreements are reached, MNDR would integrate BIMA and M&M Helix as subsidiaries, combining its Nasdaq access and AI tools with their existing telemedicine and health platforms. Actual impact will depend on valuation outcomes, regulatory clearances and the parties’ ability to finalize binding agreements.

Potential investment up to US$119 million Hector Capital may invest to fund MNDR’s acquisitions and corporate purposes
Strategic Cooperation Framework Memorandum of Understanding financial
"entered into a non-binding Strategic Cooperation Framework Memorandum of Understanding"
non-binding regulatory
"The MOU is strictly non-binding in its entirety and serves as the basis"
"Non-binding" describes an agreement or statement that does not legally require the parties involved to follow through with its terms. It’s like a handshake or a written promise that shows intent but isn’t enforceable by law. For investors, understanding whether an agreement is binding or non-binding helps gauge how seriously the parties are committed and how much weight to give to the promises made.
independent valuation financial
"Consideration for the acquisitions will be consistent with an independent valuation of BIMA and MM Helix"
An independent valuation is an assessment of the fair value of a company, asset, security or transaction performed by an outside, impartial expert rather than by the issuing company. It matters to investors because it provides a neutral “price check” — like hiring an inspector before buying a house — helping reveal whether a price is reasonable, supporting deal pricing and financing decisions, and reducing conflicts of interest in negotiations or reporting.
Nasdaq listing rules regulatory
"remains subject to regulatory approvals under applicable Nasdaq listing rules and Singapore law"
Nasdaq listing rules are the rulebook a company must follow to have its shares traded on the Nasdaq stock exchange, covering entry requirements and ongoing standards for finances, corporate governance, public disclosure and reporting. For investors they matter because the rules create baseline checks — like a driver’s license and regular inspections for a car — that promote transparency, comparability and reduce the risk of fraud or sudden delisting.
forward-looking statements regulatory
"This report on Form 6-K contains forward-looking statements within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of May 2026

 

Commission file number: 001-41990

 

 

 

Mobile-health Network Solutions

(Exact name of registrant as specified in its charter)

 

 

 

2 Venture Drive, #07-08 Vision Exchange

Singapore 608526

+65 6222 5223

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

 

 

 

 
 

 

Entry into a Strategic Cooperation Framework Memorandum of Understanding.

 

On April 30, 2026, Mobile-health Network Solutions (the “Company”) entered into a non-binding Strategic Cooperation Framework Memorandum of Understanding (“MOU”) with Hector Capital Holdings Pte. Ltd. (“Hector Capital”) regarding a proposed strategic cooperation. Pursuant to the MOU, Hector Capital may invest up to US$119 million into the Company to support the Company’s potential acquisition of majority interests in MILVIK SINGAPORE PTE. LTD. (“BIMA”) and M&M Helix Pte. Ltd. (“MM Helix”), subject to the completion of the Company’s full due diligence on BIMA and MM Helix, entry into definitive agreements, regulatory approval, and independent valuation.

 

On May 4, 2026, the Company issued a press release announcing its entry into the MOU. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 6-K.

 

Forward-Looking Statements

 

This report on Form 6-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, statements regarding the ability to successfully execute on the plans and undertakings contemplated in the agreements discussed in this report.

 

Additional forward-looking statements can be identified by terminology such as “may,” “might,” “could,” “will,” “aims,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to a number of risks. The reader should not place undue reliance on these forward-looking statements, as there can be no assurances that the plans, initiatives or expectations upon which they are based will occur. A detailed discussion of these factors and other risks that affect our business is included in filings we make with the SEC from time to time. Copies of these filings are available online from the SEC at www.sec.gov, or on the SEC Filings section of our Investor Relations website at https://investors.manadr.com/sec-filings. All forward-looking statements in this press release are based on information currently available to us, and we assume no obligation to update these forward-looking statements in light of new information or future events.

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Press release

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Mobile-health Network Solutions
   
Date: May 4, 2026 By: /s/ Siaw Tung Yeng
    Siaw Tung Yeng
    Co-Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

 

Mobile-health Network Solutions Enters into Non-binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa

 

Singapore, May 4, 2026 – Mobile-health Network Solutions (Nasdaq: MNDR) (“MNDR” or the “Company”), a leading AI-powered digital health platform, today announced the signing of a non-binding Strategic Cooperation Framework Memorandum of Understanding (“MOU”) with Hector Capital Holdings Pte. Ltd. (“Hector Capital”). Under the framework, Hector Capital will invest up to US$119 million into MNDR to support the acquisition of majority shareholdings in MILVIK Singapore Pte. Ltd. (“BIMA”), a healthcare platform operating in Asia and Africa, and M&M Helix Pte. Ltd. (“MM Helix”), a healthcare technology firm offering an AI-powered telemedicine and patient care platform.

 

This strategic partnership marks a significant milestone in MNDR’s mission to expand its portfolio of AI-powered healthcare solutions across Asia and Africa.

 

Transaction Highlights

 

Capital Investment: Hector Capital to invest up to US$119 million in MNDR, with the funding structure to be finalized in the definitive agreements, which may include a combination of equity subscription, convertible instruments, and/or other financial instruments. Proceeds will be applied toward the acquisitions and for general corporate and operational purposes.
   
Acquisitions: MNDR to acquire majority stakes in BIMA and MM Helix, integrating them as subsidiaries.
   
Independent Valuation: Consideration for the acquisitions will be consistent with an independent valuation of BIMA and MM Helix to be commissioned and agreed to by the parties prior to execution of the definitive agreements, and remains subject to regulatory approvals under applicable Nasdaq listing rules and Singapore law.

 

About the Targets

 

M&M Helix Pte. Ltd.: A Singapore-based digital healthcare technology firm offering an AI-powered telemedicine and patient care platform. MM Helix recently expanded its capabilities through the acquisition of Hyderabad-based health-tech firm Zibew, operator of DigitalRx.io, enabling a unified system for clinic and pharmacy workflows.
   
MILVIK BIMA: Founded in 2010, BIMA is a pioneer in democratising healthcare in emerging markets. Its platform provides affordable access to telemedicine, specialist care, health screening, personalized health programs, medicine delivery, laboratory testing, and insurance. Operating across Asia and Africa, BIMA serves millions of customers and is committed to making high-quality healthcare accessible to all.

 

 
 

 

 

Strategic Value

 

By combining MNDR’s Nasdaq listing, market access, and operational expertise with Hector Capital’s investment, ongoing strategic advisory support, and introductions to relevant business networks, the partnership will:

 

Accelerate growth of BIMA and MM Helix through expanded digital health offerings.
   
Enhance efficiency by leveraging MNDR’s AI-driven tele-consultation and workflow automation.
   
Broaden access to affordable healthcare across Asia and Africa.

 

Dr. Siaw Tung Yeng, Co-CEO of MNDR, commented, “This framework sets the stage for transformative growth. By integrating BIMA’s healthcare ecosystem and MM Helix’s AI-powered platform into MNDR, we are building a scalable, affordable healthcare network that empowers millions of families across emerging markets.”

 

Vikash, representing Hector Capital Holdings, added, “Our investment underscores confidence in MNDR’s vision. Together, we will unlock synergies that drive profitability, reduce costs through AI, and expand access to healthcare globally.”

 

The MOU is strictly non-binding in its entirety and serves as the basis for negotiating definitive agreements, including an Investment Agreement and Share Purchase Agreements. Completion remains subject to MNDR’s full legal, financial, and operational due diligence on BIMA and MM Helix, independent valuation, and receipt of all necessary regulatory approvals, including those required under applicable Nasdaq listing rules and Singapore law.

 

About Hector Capital Holdings

 

Hector Capital Holdings Pte. Ltd. is a Singapore-based investment firm with substantial indirect and beneficial shareholdings in regulated fund management entities VPAM and Brown Capital, operating across multiple jurisdictions. The firm specializes in strategic investments that combine capital deployment with operational value-add, supporting portfolio companies in scaling across Asia and beyond.

 

Through majority ownership interests in MILVIK Singapore Pte. Ltd. (BIMA) and M&M Helix Pte. Ltd., Hector Capital has built a strong presence in the digital healthcare sector. Its investment philosophy emphasizes:

 

Long-term growth through technology-driven healthcare solutions.
   
Cross-border structuring to enable expansion into emerging markets.
   
Strategic partnerships that leverage both financial strength and advisory expertise.

 

By partnering with MNDR, Hector Capital is reinforcing its commitment to democratizing healthcare access and accelerating the adoption of AI-powered platforms that improve patient outcomes and operational efficiency.

 

 
 

 

 

 

About Mobile-health Network Solutions

 

Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit our website.

 

Forward-Looking Statements

 

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company’s transition to an asset-light platform, the Company’s goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s ability to execute our strategies, manage growth and maintain our corporate culture; the Company’s future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.

 

For media inquiries, please contact:

 

Mobile-health Network Solutions Investor Relations Contact:

 

2 Venture Drive, #07-08 Vision Exchange

Singapore 608526

(+65) 6222 5223

Email: investors@manadr.com

 

Investor Relations Inquiries:

 

Skyline Corporate Communications Group, LLC

Scott Powell, President

1177 Avenue of the Americas, 5th Floor

New York, New York 10036

Office: (646) 893-5835

Email: ir@skylineccg.com

 

 

 

FAQ

What did Mobile-health Network Solutions (MNDR) announce in this Form 6-K?

Mobile-health Network Solutions announced a non-binding Strategic Cooperation Framework MOU with Hector Capital. The arrangement contemplates Hector Capital investing up to US$119 million to support potential majority acquisitions of BIMA and M&M Helix, expanding MNDR’s AI-powered healthcare presence in Asia and Africa if completed.

How much could Hector Capital invest in MNDR under the MOU?

Hector Capital may invest up to US$119 million in Mobile-health Network Solutions. The final funding structure will be set in definitive agreements and could include equity subscriptions, convertible instruments, or other financial instruments, with proceeds used for the BIMA and M&M Helix acquisitions and general corporate purposes.

Which companies does MNDR plan to acquire with Hector Capital’s support?

MNDR plans to acquire majority stakes in MILVIK Singapore Pte. Ltd. (BIMA) and M&M Helix Pte. Ltd. The goal is to integrate these digital healthcare platforms as subsidiaries, enhancing MNDR’s AI-powered telemedicine and patient care offerings across emerging markets in Asia and Africa if the deals close.

Is the US$119 million MNDR and Hector Capital agreement binding?

No, the Strategic Cooperation Framework MOU between MNDR and Hector Capital is strictly non-binding. It serves as a basis for negotiating an Investment Agreement and Share Purchase Agreements, all subject to due diligence, independent valuation, and regulatory approvals under Nasdaq listing rules and Singapore law.

What conditions must be met before MNDR’s acquisitions of BIMA and M&M Helix proceed?

Completion of the proposed acquisitions requires MNDR’s full legal, financial and operational due diligence on BIMA and M&M Helix, agreement on an independent valuation, execution of definitive transaction documents, and all necessary regulatory approvals, including those required by applicable Nasdaq listing rules and Singapore law.

How would the potential deal benefit MNDR’s healthcare platform?

If completed, the deal would add BIMA’s emerging-market healthcare ecosystem and M&M Helix’s AI-powered telemedicine platform to MNDR’s portfolio. Management highlights potential to accelerate growth, improve efficiency through AI-driven automation, and broaden access to affordable digital healthcare across Asia and Africa through integrated offerings.

Filing Exhibits & Attachments

2 documents